Stent Implantation Across the Atrial Flow Regulator Device
- PMID: 38308059
- DOI: 10.1007/s00246-024-03405-z
Stent Implantation Across the Atrial Flow Regulator Device
Abstract
The Atrial Flow Regulator (AFR) is a self-expandable double-disc device with a central fenestration, intended to maintain a calibrated communication across the interatrial septum. We reported for the first time a stent implantation across an AFR device in an adolescent born with complex congenital heart disease with duct-dependent systemic circulation and severe combined pulmonary hypertension.
Keywords: Atrial Flow Regulator; Congenital heart disease; Heart failure; Pulmonary hypertension; Stent implantation.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Shah SJ, Borlaug BA, Chung ES et al, REDUCE LAP-HF II investigators (2022) Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet 399(10330):1130–1140
-
- Paitazoglou C, Bergmann MW (2020) The atrial flow regulator: current overview on technique and first experience. Ther Adv Cardiovasc Dis. https://doi.org/10.1177/1753944720919577 - DOI - PubMed - PMC
-
- Piccinelli E, Testa A, Butera G (2023) Versatility of atrial flow regulator device in congenital heart disease: a case series. Pediatr Cardiol. https://doi.org/10.1007/s00246-023-03123-y - DOI - PubMed
-
- O’Callaghan B, Zablah J, Vettukattil J et al (2021) Multi-Institutional US Experience of the Occlutech© AFR device in congenital and acquired heart disease. Congenit Heart Dis 17(1):107–116 - DOI